311 related articles for article (PubMed ID: 32614678)
41. Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII.
Kumar S; Ceruso M; Tuccinardi T; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2907-2913. PubMed ID: 27166574
[TBL] [Abstract][Full Text] [Related]
42. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
[TBL] [Abstract][Full Text] [Related]
43. 1,2,3-Benzoxathiazine-2,2-dioxides - effective inhibitors of human carbonic anhydrases.
Ivanova J; Abdoli M; Nocentini A; Žalubovskis R; Supuran CT
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):225-238. PubMed ID: 36373195
[TBL] [Abstract][Full Text] [Related]
44. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
45. Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII.
Carta F; Maresca A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2012 Apr; 20(7):2266-73. PubMed ID: 22377674
[TBL] [Abstract][Full Text] [Related]
46. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
[TBL] [Abstract][Full Text] [Related]
47. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.
Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936
[TBL] [Abstract][Full Text] [Related]
48. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
49. Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors.
Moi D; Vittorio S; Angeli A; Balboni G; Supuran CT; Onnis V
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615285
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M
Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and biological evaluation of coumarin-thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Newaskar V; Angeli A; Sigalapalli DK; Goud NS; Chirra H; Shaik AB; Arifuddin M; Supuran CT
Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200232. PubMed ID: 36122182
[TBL] [Abstract][Full Text] [Related]
52. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
Nocentini A; Carta F; Ceruso M; Bartolucci G; Supuran CT
Bioorg Med Chem; 2015 Nov; 23(21):6955-66. PubMed ID: 26432607
[TBL] [Abstract][Full Text] [Related]
53. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
54. Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII.
Redij A; Carradori S; Petreni A; Supuran CT; Toraskar MP
Anticancer Agents Med Chem; 2023; 23(10):1217-1223. PubMed ID: 36825712
[TBL] [Abstract][Full Text] [Related]
55. Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms.
Eldehna WM; Taghour MS; Al-Warhi T; Nocentini A; Elbadawi MM; Mahdy HA; Abdelrahman MA; Alotaibi OJ; Aljaeed N; Elimam DM; Afarinkia K; Abdel-Aziz HA; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):531-541. PubMed ID: 34991416
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII.
Bozdag M; Alafeefy AM; Altamimi AM; Carta F; Supuran CT; Vullo D
Bioorg Med Chem; 2017 May; 25(10):2782-2788. PubMed ID: 28389112
[TBL] [Abstract][Full Text] [Related]
58. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids.
Winum JY; Innocenti A; Scozzafava A; Montero JL; Supuran CT
Bioorg Med Chem; 2009 May; 17(10):3649-52. PubMed ID: 19375921
[TBL] [Abstract][Full Text] [Related]
59. 5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors.
Cornelio B; Laronze-Cochard M; Miambo R; De Grandis M; Riccioni R; Borisova B; Dontchev D; Machado C; Ceruso M; Fontana A; Supuran CT; Sapi J
Eur J Med Chem; 2019 Aug; 175():40-48. PubMed ID: 31071549
[TBL] [Abstract][Full Text] [Related]
60. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
